Tomorrows FM

With all the latest laboratory science news, stories and unique features to your desktop, tablet or smartphone, Tomorrow's Laboratories is your digital Laboratory Science magazine: a portal for all your lab news.

Tecan to launch Fluent Gx Automation Workstation for regulated laboratories

Published on 26/01/2018

Tecan’s range of advanced liquid handling solutions will soon be enhanced with the introduction of the new Fluent Gx Automation Workstation, designed to meet the stringent needs of clinical and regulated laboratories.

New report provides vital insights for new medicine development

Published on 22/01/2018

A new joint report, ‘State of the Discovery Nation 2018’ by the Medicines Discovery Catapult and the BioIndustry Association, has been launched by Sir Mark Walport to provide unique insights into the productivity of the UK’s drug discovery community, and the challenges and opportunities it faces.

Ingenza embarks on ConBioChem collaboration

Published on 17/01/2018

Ingenza has joined forces with leading universities and industrial partners to participate in the ConBioChem collaboration, a translational project focused on the development of novel platform technologies for the continuous bio-production of commodity chemicals.

Remote Access/Network Connected autoclaves released by Astell

Published on 8/01/2018

Sterilisation specialist Astell Scientific has released its latest Remote Management/Diagnosis product option, enabling secure network connectivity, remote access, and diagnostics on any of its compatible circular or square section autoclaves.

Precision NanoSystems one of BC’s fastest growing companies

Published on 20/12/2017

Precision NanoSystems is one of the fastest growing businesses in British Columbia (BC) according to the recently published list from news journal Business in Vancouver (BIV).

SpeeDx Pty. Ltd. establishes US-based operation

Published on 11/12/2017

SpeeDx Pty. Ltd, a developer of advanced multiplex molecular diagnostic solutions, announced the incorporation of a US-based subsidiary company, SpeeDx Inc. It will use the US base to support current clinical trial activity for ResistancePlus™ MG in preparation for an expected 2018 launch.

Twitter feed

Visit our other websites